SCILEX HOLDING CO SCLXW
*W EXP 11/10/202 · Equity WRT · CUSIP 80880W114
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersPalo Alto, CA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.13.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2022 | 27 |
| Q1 2023 | 11 |
| Q2 2023 | 11 |
| Q3 2023 | 8 |
| Q4 2023 | 7 |
| Q1 2024 | 9 |
| Q2 2024 | 10 |
| Q3 2024 | 10 |
| Q4 2024 | 10 |
| Q1 2025 | 8 |
| Q2 2025 | 6 |
| Q3 2025 | 5 |
| Q4 2025 | 6 |
| Q1 2026 | 4 |
| Q2 2026 | 5 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2024 | 2 | 2 |
| Q4 2024 | 1 | 2 |
| Q1 2025 | 1 | 3 |
| Q2 2025 | 2 | 4 |
| Q3 2025 | 0 | 0 |
| Q4 2025 | 3 | 1 |
| Q1 2026 | 0 | 4 |
| Q2 2026 | 1 | 1 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2025 | $3.6k | $0 | 0.00 |
| Q4 2025 | $0 | $0 | — |
| Q1 2026 | $0 | $0 | — |
| Q2 2026 | $0 | $0 | — |
Biggest buyers
| UBS Group AG | New | +155 |
Biggest sellers
| Virtu Financial LLC | Reduced | -3.4k |
Insider purchases and sales since 1 Apr 2026
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q4 2024 | 7 | $126.3k | 0 | — | — |
| Q1 2025 | 0 | — | 0 | — | — |
| Q2 2025 | 0 | — | 0 | — | — |
| Q3 2025 | 0 | — | 0 | — | — |
| Q4 2025 | 0 | — | 0 | — | — |
| Q1 2026 | 0 | — | 0 | — | — |
| Q2 2026 | 0 | — | 0 | — | — |
| Q3 2026 | 0 | — | 0 | — | — |
None reported since 1 Apr 2026.
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| Cruiser Capital Advisors, LLC 0.00% of their portfolio | 50.0k $6.5k | Unchanged |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 0.00% of their portfolio | 42.3k $5.5k | Unchanged |
| Virtu Financial LLC 0.00% of their portfolio | 34.8k $4.0k | Reduced -3.4k |
| Clear Street Group Inc. 0.00% of their portfolio | 2.9k $374 | Unchanged |
| UBS Group AG 0.00% of their portfolio | 155 $20 | New |